Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Biologics Study Results of IBI303 in Patients with Ankylosing Spondylitis was Published in "The Lancet Rheumatology" 2019-08-30 17:38
Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon 2019-08-30 05:05
DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds 2019-08-30 01:59
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India 2019-08-29 20:04
Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines 2019-08-29 16:34
Taiho Pharmaceutical Invests in New Venture Capital Fund 2019-08-29 13:00
Viva Biotech Announces 2019 Interim Results 2019-08-29 11:12
Innovent Reports Interim Results for Fiscal Year 2019 2019-08-29 08:39
Medtec China 2019 to inaugurate on September 25 in Shanghai 2019-08-28 11:12
Ascletis Received IND Approval for its NASH Drug 2019-08-28 08:00
LBB Specialties Announces Strategic Partnership With MEGGLE On US Distribution Of Excipient Products 2019-08-28 06:00
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 2019-08-28 04:16
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 2019-08-28 04:16
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas 2019-08-27 22:24
Health Canada Clears Fotona Dynamis for Stress Urinary Incontinence (SUI) and Vulvovaginal Atrophy (VVA) / Genitourinary Syndrome of Menopause (GSM) 2019-08-27 17:05
InDex Pharmaceuticals Meets Primary Endpoint in the Phase IIb Study CONDUCT with Cobitolimod in Ulcerative Colitis 2019-08-27 14:04
DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration 2019-08-27 07:00
CStone announces first patient dosed in China for Phase I/II registrational bridging trial of avapritinib in advanced GIST 2019-08-26 11:21
Atonarp Inc. Announces $33 Million Series C Funding Round Completion 2019-08-26 07:00
Concord Medical Reports Financial Results for the First Half of 2019 2019-08-24 06:00
1 626 627 628 629 630 962